Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 20, 2016
Patent Application Number
14858416
Date Filed
September 18, 2015
Patent Citations Received
0
Patent Primary Examiner
Patent abstract
Provided are antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping, and methods of use thereof to treat muscular dystrophy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
